Trial Outcomes & Findings for Extubation With or Without Spontaneous Breathing Trial (NCT NCT01020773)

NCT ID: NCT01020773

Last Updated: 2009-11-26

Results Overview

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

67 participants

Primary outcome timeframe

13 months

Results posted on

2009-11-26

Participant Flow

Participant milestones

Participant milestones
Measure
SBT Group
In the Spontaneous Breathing Trial(SBT) group, the patients underwent a 1 hr SBT with Inspiratory Support Pressure(PS) of 7 cmH2O with other settings remaining constant (FiO2, PEEP, trigger sensitivity). The patients who tolerated the SBT underwent immediate extubation.
No-SBT Group
In no-SBT group, as soon as a patient met readiness criteria, he or she underwent extubation without SBT process.
Overall Study
STARTED
35
32
Overall Study
COMPLETED
31
29
Overall Study
NOT COMPLETED
4
3

Reasons for withdrawal

Reasons for withdrawal
Measure
SBT Group
In the Spontaneous Breathing Trial(SBT) group, the patients underwent a 1 hr SBT with Inspiratory Support Pressure(PS) of 7 cmH2O with other settings remaining constant (FiO2, PEEP, trigger sensitivity). The patients who tolerated the SBT underwent immediate extubation.
No-SBT Group
In no-SBT group, as soon as a patient met readiness criteria, he or she underwent extubation without SBT process.
Overall Study
Withdrawal by Subject
4
3

Baseline Characteristics

Extubation With or Without Spontaneous Breathing Trial

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
SBT Group
n=35 Participants
In the Spontaneous Breathing Trial(SBT) group, the patients underwent a 1 hr SBT with Inspiratory Support Pressure(PS) of 7 cmH2O with other settings remaining constant (FiO2, PEEP, trigger sensitivity). The patients who tolerated the SBT underwent immediate extubation.
No-SBT Group
n=32 Participants
In no-SBT group, as soon as a patient met readiness criteria, he or she underwent extubation without SBT process.
Total
n=67 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
1 Participants
n=7 Participants
1.0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
20 Participants
n=5 Participants
18 Participants
n=7 Participants
38.0 Participants
n=5 Participants
Age, Categorical
>=65 years
15 Participants
n=5 Participants
13 Participants
n=7 Participants
28.0 Participants
n=5 Participants
Age Continuous
58.9 years
STANDARD_DEVIATION 16.3 • n=5 Participants
56.7 years
STANDARD_DEVIATION 18.0 • n=7 Participants
57.9 years
STANDARD_DEVIATION 17.1 • n=5 Participants
Sex: Female, Male
Female
13 Participants
n=5 Participants
12 Participants
n=7 Participants
25.0 Participants
n=5 Participants
Sex: Female, Male
Male
22 Participants
n=5 Participants
20 Participants
n=7 Participants
42.0 Participants
n=5 Participants

PRIMARY outcome

Timeframe: 13 months

Outcome measures

Outcome measures
Measure
SBT Group
n=31 Participants
In the Spontaneous Breathing Trial(SBT) group, the patients underwent a 1 hr SBT with Inspiratory Support Pressure(PS) of 7 cmH2O with other settings remaining constant (FiO2, PEEP, trigger sensitivity). The patients who tolerated the SBT underwent immediate extubation.
No-SBT Group
n=29 Participants
In no-SBT group, as soon as a patient met readiness criteria, he or she underwent extubation without SBT process.
Number of Participants With Successful Extubation, Reintubation and in Hospital Mortality
Successful extubation
28 participants
29 participants
Number of Participants With Successful Extubation, Reintubation and in Hospital Mortality
Reintubation
3 participants
3 participants
Number of Participants With Successful Extubation, Reintubation and in Hospital Mortality
In hospital mortality
3 participants
4 participants

Adverse Events

SBT Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

No-SBT Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Department of Respiratory Medicine

Beijing Shijitan Hospital

Phone: 86-010-63926385

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place